ANTG produces exclusive high-quality cannabinoid based medicinal treatments that can meet individual patient needs.
ANTG's focus is on putting the needs of patients first – and they believe, as an independent company, that they are uniquely positioned to achieve more.
ANTG is committed to investing in research and development, both in-house as well as partnering with key universities to undertake cannabis research and support clinical trial programs.
Led by a board of skilled commercial leaders, the ANTG team also includes experienced horticulturists, scientific researchers and medical advisors.
BOD Australia is a CBD and Hemp healthcare company.
By leading the way in research and development, BOD's mission is to innovate and transform the way we live and enjoy life through the delivery of premium, proven and trusted global products for both the consumer and healthcare professional.
Inspired from its work in research, clinical trials and partnerships, BOD is building a suite of products across a range of indications within the healthcare industry.
Bod Australia’s Pharmaceutical-grade, medicinal cannabis is now available in the UK and Australia with new markets being opened around the globe.
Medifarm Tikun has changed its name to Tikun Australia, but remains proudly 100% Australian.
At Tikun Australia each team member contributes, having either experienced their own health challenges and/or have a story to share of a friend, family member or a member of the community. We are passionate about what we do.
Tikun Australia is proud to partner with Tikun Olam, pioneers and world leaders in medicinal cannabis, to provide Australian patients with the most advanced medical cannabis treatments, supported by global research into plant science, manufacturing, and therapeutic outcomes.
Cannatrek was founded in 2015.
By 2017, it had obtained the second cannabis research licence, to begin its journey to provide a better quality of life to Australian patients.
Its mission is to provide affordable care through its unique ‘seed to patient’ model.
Cannatrek aims to improve the accessibility of medicinal cannabis through lower prices, easier access and better education for patients and doctors.
iX Syrinx is an expanding global company that is dedicated to improving health outcomes for its clients.
Its scientists combine formulation know-how and oral, topical or sublingual delivery technologies to create unique and innovative solutions for pharmaceutical use and consumer health.
Scitek is the only ANZ based specialist cannabis manufacturing equipment supplier.
We have >30 years pharmaceutical industry experience. Scitek’s focus is on providing honest production technology consulting, efficient ASNZ and GMP standard compliant equipment supply and benchmark service.
Cymra Life Sciences is an Australian-owned licenced cultivator and manufacturer of medical cannabis focusing on cultivating full spectrum medicines for people living in chronic and neuropathic pain.
It is the only cannabis company in Australia focusing on genetic development and supply to cannabis cultivators.
United in Compassion is Australia’s peak medicinal cannabis advocacy body founded in 2014 by Lucy Haslam and her late son Dan who benefited dramatically from medicinal cannabis during his battle with cancer.
Though he passed away in 2015, his legacy lives on through the 2016 legislative changes making lawful cultivation of the plant for medical and research purposes possible.
The Country Women’s Association of Australia (CWAA) was formed in 1945 to provide a single voice to the Federal Government on behalf of the individual State and Territory Associations.
Its objective is to advance the rights and equity of women, families and communities in Australia through advocacy and empowerment, especially for those living in regional, rural and remote Australia.
The founder of United in Compassion, the leading NGO for medicinal cannabis, Lucy Haslam is also a founding member, Board Director and Chair of AMCA.
Passionate about access and affordability for patients, Lucy registered UIC (https://unitedincompassion.com.au/), as a member organisation of AMCA as soon as it was formed, and will work through both associations to advocate for, and further the interests of, patients in need.
Lucy continues to campaign tirelessly and, as well as organising the 2021 UIC Symposium being held from August 13-15 2021 at the Sunshine Coast, she has also been instrumental in driving the development of the online Australian Medicinal Cannabis Course For Health Professionals which has just launched (https://medicalcannabiscourse.com.au)
We are currently welcoming other organisations to become members to help us to shape the future of our industry for the benefit of the sector and the patients and carers that it serves.
Jodie was the first person to sign up for individual membership on the day that AMCA launched - 15th July 2020
Jodie is, in her own words, a "huge advocate for medicinal cannabis". As well as being a member of United in Compassion, Jodie is Federal Education Officer of the Australian Nursing and Midwifery Federation and has been charged with developing a conference (post-Covid 19) for nurses and midwives about Medicinal Cannabis. She has also written an education piece for nurses and midwives which is available on the online education portal (http://anmf.org.au/education).
We look forward to welcoming many more individuals to join AMCA and its member organisations to make this unique treatment more accessible and affordable. for patients.